These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 25669425)
21. Clinical Outcomes of Mammographic BI-RADS 3 Lesions in the Community Hospital Setting. Friedman P; Kerwin L; Chung J Can Assoc Radiol J; 2016 Nov; 67(4):313-317. PubMed ID: 27523446 [TBL] [Abstract][Full Text] [Related]
22. Probably benign lesions at screening breast US in a population with elevated risk: prevalence and rate of malignancy in the ACRIN 6666 trial. Barr RG; Zhang Z; Cormack JB; Mendelson EB; Berg WA Radiology; 2013 Dec; 269(3):701-12. PubMed ID: 23962417 [TBL] [Abstract][Full Text] [Related]
23. Mammographic characteristics and vacuum-assisted breast biopsy (VABB) of non-palpable breast lesions. Ventrella V; Tufaro A; Zito FA; Addante M; Stea B; Dentamaro R; D'Amico C; Paradiso A Acta Radiol; 2011 Jul; 52(6):602-7. PubMed ID: 21565889 [TBL] [Abstract][Full Text] [Related]
24. Use of the American College of Radiology BI-RADS guidelines by community radiologists: concordance of assessments and recommendations assigned to screening mammograms. Lehman C; Holt S; Peacock S; White E; Urban N AJR Am J Roentgenol; 2002 Jul; 179(1):15-20. PubMed ID: 12076896 [TBL] [Abstract][Full Text] [Related]
25. [Performance of users in tropical areas with the BI-RADS classification of breast lesions for predicting malignancy]. Gonsu Kamga JE; Moifo B; Sando Z; Guegang Goudjou E; Nko'o Amvene S; Gonsu Fotsin J Med Sante Trop; 2013; 23(4):439-44. PubMed ID: 24334372 [TBL] [Abstract][Full Text] [Related]
26. Mammographic surveillance after MammoSite breast brachytherapy: analysis of architectural patterns and additional interventions. Dragun AE; Jenrette JM; Ackerman SJ; Irshad A; Pope TL Am J Clin Oncol; 2007 Dec; 30(6):574-9. PubMed ID: 18091050 [TBL] [Abstract][Full Text] [Related]
27. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value. Lazarus E; Mainiero MB; Schepps B; Koelliker SL; Livingston LS Radiology; 2006 May; 239(2):385-91. PubMed ID: 16569780 [TBL] [Abstract][Full Text] [Related]
28. First ultrasound diagnosis of BI-RADS 3 lesions in young patients: Can 6-months follow-up be sufficient to assess stability? Marcon M; Frauenfelder T; Becker AS; Dedes KJ; Boss A Eur J Radiol; 2017 Apr; 89():226-233. PubMed ID: 28267544 [TBL] [Abstract][Full Text] [Related]
29. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value? Uematsu T; Yuen S; Kasami M; Uchida Y Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274 [TBL] [Abstract][Full Text] [Related]
30. [Second reading of breast imaging at the hospital department of radiology: reasonable or waste of money?]. Teifke A; Vomweg TW; Hlawatsch A; Nasresfahani A; Kern A; Victor A; Schmidt M; Bittinger F; Düber C Rofo; 2006 Mar; 178(3):330-6. PubMed ID: 16508842 [TBL] [Abstract][Full Text] [Related]
31. Role of combined BI-RADS assessment using mammography and sonography for evaluation of incidental hypermetabolic lesions in the breast on 18F-FDG PET-CT. Lim S; Lee EH; Park JM; Chang YW; Kim HH; Jeong SH Acta Radiol; 2013 Dec; 54(10):1117-24. PubMed ID: 23864064 [TBL] [Abstract][Full Text] [Related]
32. Lesion and patient characteristics associated with malignancy after a probably benign finding on community practice mammography. Lehman CD; Rutter CM; Eby PR; White E; Buist DS; Taplin SH AJR Am J Roentgenol; 2008 Feb; 190(2):511-5. PubMed ID: 18212240 [TBL] [Abstract][Full Text] [Related]
33. Predictive value of BI-RADS classification for breast imaging in women under age 50. Kennedy G; Markert M; Alexander JR; Avisar E Breast Cancer Res Treat; 2011 Dec; 130(3):819-23. PubMed ID: 21748292 [TBL] [Abstract][Full Text] [Related]
34. Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted? Graf O; Helbich TH; Fuchsjaeger MH; Hopf G; Morgun M; Graf C; Mallek R; Sickles EA Radiology; 2004 Dec; 233(3):850-6. PubMed ID: 15486217 [TBL] [Abstract][Full Text] [Related]
35. Positive predictive value of breast cancer in the lesions categorized as BI-RADS category 5. Wiratkapun C; Lertsithichai P; Wibulpholprasert B J Med Assoc Thai; 2006 Aug; 89(8):1253-9. PubMed ID: 17048437 [TBL] [Abstract][Full Text] [Related]
36. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41. Hooley RJ; Greenberg KL; Stackhouse RM; Geisel JL; Butler RS; Philpotts LE Radiology; 2012 Oct; 265(1):59-69. PubMed ID: 22723501 [TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance imaging of the breast as a problem-solving method: to be or not to be? Oztekin PS; Kosar PN Breast J; 2014; 20(6):622-31. PubMed ID: 25200378 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness of assigning BI-RADS category-3 to breast lesion with respect to follow-up. Masroor I J Coll Physicians Surg Pak; 2008 Apr; 18(4):209-12. PubMed ID: 18474152 [TBL] [Abstract][Full Text] [Related]
40. Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? A retrospective analysis stratified by mammographic BI-RADS classes. Benndorf M; Baltzer PA; Vag T; Gajda M; Runnebaum IB; Kaiser WA Acta Radiol; 2010 Sep; 51(7):715-21. PubMed ID: 20707656 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]